Sale of Securities

Aldeyra Therapeutics, Inc. Filed 2024-03-11 Acc 0001972362-24-000397

Documents 1

2024-03-12 144 Sale of Securities
2024-03-12 4 See Remarks sold 13,201 shares at $3.41 ($44,968)
2024-03-12 4 Chief Development Officer sold 29,768 shares at an average $3.31 ($98,605)
2024-03-12 4 President and CEO sold 183,238 shares at an average $3.17 ($580,760)
2024-03-11 144 Sale of Securities
2024-03-11 144 Sale of Securities
2024-03-11 144 Sale of Securities

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…